Tetra Pharm Technologies and Glysious to Develop Transdermal Combination Drugs
Tetra Pharm Technologies has joined forces with Glysious, to develop a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates.
Endocannabinoid System | 25/04/2024 | By Aishwarya | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy